BioXell
Bioxell is a leading provider of therapeutic antibody development, bioprocess development, recombinant protein and antibody production, peptide synthesis, and cell line services. The company focuses on creating high-quality, innovative solutions to advance life sciences and healthcare, serving global research, diagnostics, and therapeutic needs.
Industries
Nr. of Employees
small (1-50)
BioXell
Rudolf Diesel Strasse 11, 69115 Heidelberg / Germany
Products
Catalog of synthetic peptides and small peptides
Online catalog of synthetic peptides and small peptide compounds offered with article numbers, molecular formulae and sequence information; samples and pricing available on request.
Catalog of synthetic peptides and small peptides
Online catalog of synthetic peptides and small peptide compounds offered with article numbers, molecular formulae and sequence information; samples and pricing available on request.
Services
End-to-end recombinant protein expression and purification across multiple host systems with tailored service strategies for research and production needs.
Generation and validation of stable cell pools and clonal cell lines for constitutive or inducible expression, using a proprietary platform for cell-line generation and functional assessment.
cGMP-aligned production cell line development including RCB generation, extended stability studies and preparation for regulatory-compliant manufacturing campaigns and tech transfer.
Design and execution of custom cell-based assays for screening, including use of custom cell lines and iPSC-derived cell types; support for in vitro toxicology and translational testing.
Custom and catalog peptide synthesis services with scale options from 0.1 mg to 1000 g and selectable purity levels up to >98%, plus documentation and sample ordering.
End-to-end recombinant protein expression and purification across multiple host systems with tailored service strategies for research and production needs.
Generation and validation of stable cell pools and clonal cell lines for constitutive or inducible expression, using a proprietary platform for cell-line generation and functional assessment.
cGMP-aligned production cell line development including RCB generation, extended stability studies and preparation for regulatory-compliant manufacturing campaigns and tech transfer.
Design and execution of custom cell-based assays for screening, including use of custom cell lines and iPSC-derived cell types; support for in vitro toxicology and translational testing.
Custom and catalog peptide synthesis services with scale options from 0.1 mg to 1000 g and selectable purity levels up to >98%, plus documentation and sample ordering.
Expertise Areas
- Recombinant protein production
- Stable cell line development
- cGMP production cell line development
- Peptide synthesis (research to production scale)
Key Technologies
- Transient expression
- Stable cell line generation
- CHO-based production workflows
- Fed-batch culture characterization
News & Updates
Bioxell is hiring and encourages experienced professionals to apply. Send your CV via email.
Bioxell aims to be among the top global suppliers of solutions for life sciences, diagnostics, and therapies.
Bioxell is hiring and encourages experienced professionals to apply. Send your CV via email.
Bioxell aims to be among the top global suppliers of solutions for life sciences, diagnostics, and therapies.